Drug delivery systems in urology—getting “smarter” - 20/08/11
Doi : 10.1016/j.urology.2006.03.069
Omid C. Farokhzad a, b, Jordan D. Dimitrakov b, c, ⁎ 
, Jeffrey M. Karp d, Ali Khademhosseini a, e, f, Michael R. Freeman b, c, Robert Langer d, e
, Jeffrey M. Karp d, Ali Khademhosseini a, e, f, Michael R. Freeman b, c, Robert Langer d, e a Department of Anesthesiology, Brigham and Women’s Hospital, Boston, Massachusetts
f Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
b Harvard Medical School, Boston, Massachusetts
c Harvard Urological Diseases Research Center, Children’s Hospital, Boston, Massachusetts
d Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts
e Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts
Reprint requests: Jordan D. Dimitrakov, M.D., Ph.D., Harvard Urological Diseases Research Center, Enders Research Building, Room 1061, 300 Longwood Avenue, Boston, MA 02115Plan
| This work was supported by National Institutes of Health/National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases grant R01 DK 065990 to J. D. Dimitrakov and in part by the Koch Research Fund, National Institutes of Health grants CA119349, EB003647, and HL60435, the Draper Laboratory, and the Institute of Soldier Nanotechnology (DAAD-19-02-D-002). J. M. Karp was supported by a Natural Sciences and Engineering Research Council of Canada fellowship. |
© 2006
Elsevier Inc. Tous droits réservés.
Vol 68 - N° 3
P. 463-469 - septembre 2006 Retour au numéro
Article précédent
- Editorial board
- Diet and benign prostatic hyperplasia: Implications for prevention
- Priyadarshi Ranjan, Diwakar Dalela, Satya Narayan Sankhwar
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?